MyoKardia (MYOK) IPO Opens 10% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
Go back to MyoKardia (MYOK) IPO Opens 10% Higher
October 29, 2015 6:01 AM EDT
ADVISORY, Oct. 29, 2015 (GLOBE NEWSWIRE) --
What:Â
MyoKardia, Inc. (Nasdaq: MYOK), a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases, will visit the Nasdaq MarketSite in Times Square to celebrate its initial public offering (IPO).
In honor of the occasion, Tassos Gianakakos, President and Chief Executive Officer, will ring the Opening Bell.Â
Where:
Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio
When:... More
October 28, 2015 7:36 PM EDT
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--
MyoKardia, Inc. (MyoKardia) today announced the pricing of its initial
public offering of 5,437,500 shares of common stock at a public offering
price of $10.00 per share, before underwriting discounts and
commissions. All of the common stock is being offered by MyoKardia. In
addition, MyoKardia has granted the underwriters a 30-day option to
purchase up to an additional 815,625 shares of common stock from the
company at the public offering price. The company's shares are expected
to begin trading on The... More
